CL vs HOTH · P/E 34, rev $20.38B vs rev $1.24B
Colgate-Palmolive Company (CL) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the CL and HOTH stock pages for the full models.
Not investment advice.